Japanese vs. European View on Amyloid Imaging and Therapy (in collaboration with JSNM)
The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However, due to differences in […]